Dr. Shiri Shulman from Assuta discusses the importance of continuity in treatment during wartime and innovative therapies ...

As the popularity of GLP-1 meds like Wegovy and Zepbound grows, fewer Americans are turning to weight-loss surgeries to trim ...

An investigational antibody demonstrated an ability to preserve vision in people with geographic atrophy from dry age-related ...

Preliminary data from a late stage clinical trial of a retinal implant showed promising results, Science Corporation said ...

Nutritional supplements that contain curcumin -- a natural anti-inflammatory compound -- may protect the eyes from the ...

Age-related macular degeneration (AMD ... it can lead to vision loss just as severe as wet AMD, but current treatments require monthly injections, have limited efficacy, can cause serious adverse ...

About Genentech in Ophthalmology Genentech is researching and developing new treatments for people living with a range of eye ...

A recent study, published in the journal Nature looked into the six-month impact of switching to faricimab instead of ...

SOL-1 is now expected to be enrolled and fully randomized by year-end 2024. Topline clinical data from SOL-1 are now expected in Q4 2025. BEDFORD, Mass., Oct. 15, 2024 (GLOBE NEWS ...

that cause retinal disease in Stargardt Disease type 1 (STGD1) and also contribute to disease progression in geographic atrophy, or advanced dry age-related macular degeneration (AMD). Bisretinoids ...